Dr. Matthew Greenblatt, an assistant professor of pathology and laboratory medicine at Weill Cornell Medicine, has been awarded the 2019 Pershing Square Sohn Prize for Young Investigators in Cancer Research to support his work studying tumor growth in bone.
Dr. Matthew Greenblatt
Credit: John Abbott
Established in 2013, the prize is awarded each year to New York-based scientists pursuing compelling cancer research and provides $200,000 in funding annually for up to three years. The Pershing Square Sohn Cancer Research Alliance supports innovative cancer research and facilitates collaborations between academia and industry in hopes of contributing to finding cures for cancer. Dr. Greenblatt will receive his award at a reception on May 22 in Manhattan.
“I’m really delighted that the resources this prize provides will let us pursue an exciting research project,” said Dr. Greenblatt, who is also a pathologist at NewYork-Presbyterian/Weill Cornell Medical Center. “The award is designed to help you pursue big-picture ideas that may not fall within the scope of traditional National Institutes of Health funding, projects that are ambitious and risky.”
